The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma

INTRODUCTION: Bortezomib has significantly improved multiple myeloma (MM) response rates, but strategies for choosing bortezomib-based regimens for initial MM therapy are not standardized. Here, we describe four bortezomib-based therapies in Chinese MM patients to determine the optimal chemotherapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jingsong, Yang, Li, Han, Xiaoyan, Zheng, Gaofeng, Zheng, Weiyan, Wei, Guoqing, Wu, Wenjun, Ye, Xiujin, Shi, Jimin, Xie, Wanzhuo, Li, Li, Zhang, Jie, Huang, Weijia, Zhao, Yi, Huang, He, Zhang, Xuejin, Fu, Jiaping, Cai, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053437/
https://www.ncbi.nlm.nih.gov/pubmed/24918626
http://dx.doi.org/10.1371/journal.pone.0099174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053437/
https://www.ncbi.nlm.nih.gov/pubmed/24918626
http://dx.doi.org/10.1371/journal.pone.0099174

Ejemplares similares